Heartflow, which provides imaging and diagnostics software for evaluating coronary artery disease, filed with the SEC to raise up to $100 million in an initial public offering. Heartflow offers a non-invasive solution for diagnosing and managing coronary artery disease (CAD). As of March 31, 2025, the Heartflow Platform has been used to assess CAD in more than 400,000 patients, including 132,000 in 2024 alone.
Read the full article: Heart Imaging Software Provider Heartflow Files for a $100M IPO //
Source: https://www.renaissancecapital.com/IPO-Center/News/112219/Heart-imaging-software-provider-Heartflow-files-for-a-$100-million-IPO